Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins

International Journal of Pharmaceutics

Volumn 342, Issue 1-2, 2007, Pages 250-253

  Brewster, Marcus E ^a   Noppe, Marc ^a   Peeters, Jef ^a   Loftsson, Thorsteinn ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Cyclodextrin; PAMPA; Permeation; Unstirred water layer

Indexed keywords

CARBAMAZEPINE; CYCLODEXTRIN; GRISEOFULVIN; HYDROCORTISONE; WATER;

ARTICLE; DRUG SOLUBILITY; DRUG STRUCTURE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ALGORITHMS; BUFFERS; CARBAMAZEPINE; CHEMISTRY, PHYSICAL; CYCLODEXTRINS; DIFFUSION; GRISEOFULVIN; HYDROCORTISONE; HYDROGEN-ION CONCENTRATION; MEMBRANES, ARTIFICIAL; PERMEABILITY; SOLUTIONS; WATER;

EID: 34547952465     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.04.029     Document Type: Article

References (14)

1. Avdeef A. Absorption and Drug Development (2003), Wiley-Interscience, New York
2. Bermejo M., Avdeef A., Ruiz A., Nalda R., Ruell J.A., Tsinman O., González I., Fernández C., Sánchez G., Garrigues T.M., and Merino V. PAMPA-a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur. J. Pharm. Sci. 21 (2004) 429-441
3. Brewster M.E., and Loftsson T. Complexation-use of cyclodextrins to improve pharmaceutical properties of intramuscular formulations. In: Gupta P.K., and Brazeau G.A. (Eds). Injectable Drug Development. Techniques to Reduce Pain and Irritation (1999), Interpharm Press, Denver 307-336
4. Cho M.J., Chen F.J., and Huczek D.L. Effects of inclusion complexation on the transepithelial transport of a lipophilic substance in vitro. Pharm. Res. 12 (1995) 560-564
5. Loftsson T., Brewster M.E., and Másson M. Role of cyclodextrins in improving oral drug delivery. Am. J. Drug Deliv. 2 (2004) 261-275
6. Loftsson T., Jarho P., Másson M., and Järvinen T. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2 (2005) 335-351
7. Loftsson T., Konrádsdóttir F., and Másson M. Development and evaluation of an artificial membrane for determination of drug availability in pharmaceutical formulations. Int. J. Pharm. 326 (2006) 60-68
8. Loftsson T., Konrádsdóttir F., and Másson M. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie 61 (2006) 83-89
9. Matsuda H., and Arima H. Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 36 (1999) 81-99
10. Mayer P., Karlson U., Christensen P.S., Johnsen A.R., and Trapp S. Quantifying the effect of medium composition on the diffusive mass transfer of hydrophobic organic chemicals through unstirred bounary layers. Environ. Sci. Technol. 39 (2005) 6123-6129
11. In: Moffat A.C., Osselton M.D., and Widdop B. (Eds). Clarke's Analysis of Drugs and Poisons (2004), Pharmaceutical Press, London
12. Nielsen P.E., and Avdeef A. PAMPA-a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer. Eur. J. Pharm. Sci. 22 (2004) 33-41
13. Uekama K., Hirayama F., and Irie T. Cyclodextrin drug carrier systems. Chem. Rev. 98 (1998) 2045-2076
14. Zhu C., Jiang L., Chen T.-M., and Hwang K.-K. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur. J. Med. Chem. 37 (2002) 399-407